Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: Ankylosing Spondylitis
This clinical trial update reports a Sohag University-sponsored study for Ankylosing Spondylitis that is not yet recruiting.
-
EMA approval · 2026-02-05EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Yuflyma (adalimumab) as a biosimilar of adalimumab for several inflammatory and autoimmune diseases, including rheumatoid art…
-
EMA approval · 2026-02-04EMA Authorised: Imraldi (adalimumab) — Samsung Bioepis NL B.V.
EMA authorised Imraldi, a biosimilar adalimumab by Samsung Bioepis NL B.V., for multiple inflammatory diseases including ankylosing spondyli…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis
A clinical trial investigating the expression of Tim-3 on neutrophils in Ankylosing Spondylitis; the study is not yet recruiting.
-
EMA approval · 2026-01-28EMA Authorised: Hukyndra (adalimumab) — Stada Arzneimittel AG
EMA authorised Hukyndra (adalimumab) from Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, psoriati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis [Phase 4]
A Phase 4 clinical trial evaluating the efficacy of secukinumab 300 mg in Chinese adults with active ankylosing spondylitis is currently rec…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Biomarkers in Ankylosing Spondylitis
A clinical trial update indicates a biomarker study for ankylosing spondylitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Effect Of Kinesiology Tape On Pain, Posture, Balance And Respiration In Ankylosing Spondylitis [NA]
This completed clinical trial evaluated the effect of kinesiology tape on pain, posture, balance, and respiration in individuals with ankylo…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis. [NA]
A clinical trial protocol evaluating whether exercise affects serum irisin levels and clinical parameters in patients with Ankylosing Spondy…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases
A clinical trial investigating skin autofluorescence as a noninvasive measure of advanced glycation end products across several rheumatic di…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis [NA]
A completed clinical trial update from Surf Therapeutics examining activation of the cholinergic anti-inflammatory pathway in healthy volunt…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Jaktinib in active Ankylosing spondylitis is ongoing and currently listed as ac…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. [Phase 3]
Phase III clinical trial update for VC005 tablets in active ankylosing spondylitis; the study is currently recruiting to assess efficacy and…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
A clinical trial update indicates a study assessing the effects of phytocannabinoids on immune response and autophagy in chronic immune-medi…
-
EMA approval · 2025-12-18EMA Authorised: Cosentyx (secukinumab) — Novartis Europharm Limited
The EMA authorised Cosentyx (secukinumab) for psoriatic arthritis, psoriasis, and ankylosing spondylitis.
-
EMA approval · 2025-12-16EMA Authorised: Erelzi (etanercept) — Sandoz GmbH
The EMA authorised Erelzi (etanercept) by Sandoz GmbH as a biosimilar to treat several inflammatory conditions including rheumatoid arthriti…
-
EMA approval · 2025-12-15EMA Authorised: Remicade (infliximab) — Janssen Cilag International NV
The EMA has authorised Remicade (infliximab) for multiple inflammatory diseases under Janssen Cilag International NV as the marketing author…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Exactech Shoulder Post Market Clinical Follow-up Study
Exactech is conducting a post-market clinical follow-up study for shoulder implants, and participant recruitment is ongoing.
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial evaluating subcutaneous netakimab in Chinese adults with active ankylosing spondylitis has completed its evaluation of efficac…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) [Phase 3]
A Phase 3 study to evaluate the efficacy and safety of drug candidate 608 in adults with active ankylosing spondylitis is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
A completed longitudinal clinical trial assessing how genetic factors influence the severity of Ankylosing Spondylitis.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Physical Training Program in Ankylosing Spondylitis [NA]
This entry reports completion of a clinical trial evaluating a physical training program for individuals with Ankylosing Spondylitis.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases [Phase 2]
Phase 2 trial evaluating the safety and efficacy of an oral capsule fecal microbiota transplant (FMT) in treatment-naïve patients with newly…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial update on the recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases; the study is active b…